IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Opaleye Management Inc.

Q1 2021 Holdings

Filed 2021-05-18 | 58 holdings | $130.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Crinetics Pharmaceuticals Inc(CRNX)COM22663K107$2.9M188,0002.2%
Cardiff Oncology Inc(CRDF)COM14147L108$5.3M576,0004.1%
Acutus Medical Inc(AFIB)COM005111109$8.2M614,9906.3%
Autolus Therapeutics PLC(AUTL)SPONSORED ADS05280R100$12.1M2,112,9189.3%
Cytokinetics Inc(CYTK)COM NEW23282W605$13.5M580,00010.3%
Celldex Therapeutics Inc(CLDX)COM NEW15117B202$20.3M985,00015.5%
Codexis Inc(CDXS)COM192005106$32.0M1,400,00024.5%
Bridgebio Pharma Inc(BBIO)COM10806X102$36.0M583,76727.5%
PreviousPage 2 of 2